Stay updated on ASPIRE Clinical Trial: PROs & Caregiver Burden in Atopic Dermatitis
Sign up to get notified when there's something new on the ASPIRE Clinical Trial: PROs & Caregiver Burden in Atopic Dermatitis page.

Latest updates to the ASPIRE Clinical Trial: PROs & Caregiver Burden in Atopic Dermatitis page
- ChecktodayChange DetectedThe study record for the ASPIRE trial is now displayed, describing its comparison of crisaborole and tacrolimus for children with atopic dermatitis and its patient- and caregiver-reported outcomes. The record indicates the study is completed and no longer recruiting.SummaryDifference50%

- Check7 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedA banner announces that NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check21 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2. The study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shifted from a 403 Forbidden error to the standard study details display, restoring access to the study record. Users can now view the study information and related details as intended.SummaryDifference0.5%

Stay in the know with updates to ASPIRE Clinical Trial: PROs & Caregiver Burden in Atopic Dermatitis
Enter your email address, and we'll notify you when there's something new on the ASPIRE Clinical Trial: PROs & Caregiver Burden in Atopic Dermatitis page.